Get To Know Us

CPGR

Meet The Team

Tim Newman

Chief Executive
Officer

Roxaan Duminy

Human Resources
Manager

Aubrey Shoko

RT-PCR Platform
Manager

Melissa Malan

Laboratory
Manager

Kenalemang Ntlhokoa

Next Generation Sequencing
Manager

Justin Naicker

Marketing
Lead

Vanessa Louw

Proteomics Platform
Manager

Mihlali Stoffels

Microarray Platform
Manager

Our Vision

To position South Africa as a global leader in the 21^st century bioeconomy – driven by innovation, infrastructure, and scientific excellence.

Our Mission

To deliver OMICS-driven solutions that close innovation gaps, unlock opportunities, and accelerate the growth of South Africa’s modern biotechnology sector

How We Work

We operate at the intersection of science, technology, and precision We deliver tailored OMICS solutions under rigorous quality management systems, ensuring reliability across research, regulatory, and commercial applications. With cutting-edge, integrated technologies, we drive results that meet the highest standards—every time.

From Concept to Discovery: Our Three-Step Approach

We turn your scientific vision into actionable outcomes through a streamlined, high-impact process:

1. Plan

We begin with a focused consultation to understand your research goals, technical needs, and desired outcomes. Together, we define the project scope – including the type and scale of OMICS analyses and ensuring alignment with your objectives and timelines.

2. Execute

We deploy cutting-edge OMICS and multi-OMICS technologies to generate high-quality, insight-rich data.
Targeted OMICS: Generate meaningful insights and identify biomarkers or molecular drivers.
Integrated Multi-OMICS: Deliver comprehensive views across systems biology.
Quality Control: Apply rigorous validation protocols to ensure data accuracy and integrity.

3. Translate

We transform complex data into clear answers.
Use robust tools and algorithms to extract relevant biological meaning.
Tailored Analysis: Adapt pipelines to your specific research questions.
Deliver results in clear, concise reports with intuitive data visualizations to support decision-making and communication.

Our Legacy

Centre for Proteomic and Genomic Research (CPGR) stands at the forefront of South Africa’s drive as a global leader in the 21st-century bioeconomy. As a catalyst for OMICS innovation (spanning Genomics, Proteomics, and Bioinformatics) we deliver high-impact, integrated solutions that advance life science research and commercial biotechnology development.

Founded in 2006 through a strategic initiative by South Africa’s Department of Science, Technology and Innovation (DSTI), and supported by the Technology Innovation Agency (TIA), CPGR was established to provide researchers and industry partners with access to advanced, capital-intensive technologies—enabling breakthroughs in publication, patenting, and product development.

All services are delivered through a robust ISO 9001:2015-certified quality management system, ensuring consistency, compliance, and scientific excellence.

CPGR has catalyzed the creation of leading biotech ventures, including Mediclinic Precise (formerly Artisan Biomed, est. 2015) and D-CYPHR (est. 2022), and currently hosts DIPLOMICS, a national OMICS infrastructure program funded by the DSI.

With over 1200 OMICS projects successfully executed, we continue to lead with the latest technologies, turning scientific ambition into measurable outcomes and contributing to a thriving biotechnology ecosystem in South Africa and beyond.

Seed & Development

2005

We kick off with a bold vision—developing our first business plan under a national initiative led by the Department of Science and Technology (DSTI), with funding support from the Technology Innovation Agency (TIA).
By December, we secure additional investment from the Cape Biotech Trust, setting the stage for what’s to come.

Establishment

2006

We officially establish ourselves as a non-profit company in April 2006, operating under Section 21 and based in Cape Town.
By September, we set up our first laboratory at the University of Cape Town (UCT), laying the groundwork for our future in OMICS innovation.

Fully Operational

2007

We go fully operational in early 2007, launching our capabilities and stepping confidently into the OMICS research landscape.

Growth & Development

2011

We expand our footprint, opening a new office at St Peter’s Square Mall in Observatory, Cape Town — a key step in scaling our operations and impact.

Initial Genomics laboratory

2012

We launch our first Genomics laboratory at St Peter’s Square Mall, Observatory, strengthening our technical capabilities and expanding our research capacity.

Next Generation Sequencing
(NGS) Laboratory

2013

We establish our Next Generation Sequencing (NGS) laboratory at St Peter’s Square Mall, taking a major leap forward in high-throughput genomic research.

ISO 9001:2008 Certification &
DIPLOMICS Launch

2014

In August, we earn ISO 9001:2008 certification, reinforcing our commitment to quality and operational excellence.

From September, we host, govern, and manage DIPLOMICS—a national, distributed OMICS platform established through the DSTI’s SARIR program—strengthening South Africa’s research infrastructure.

Artisan Biomed Spin-Off

2015

We launch Artisan Biomed to deliver precision medicine in the South African healthcare sector, combining advanced molecular testing with clinical insight through a key partnership with Lancet Laboratories.

New CPGR Facility & D-CYPHR
Launch

2022

We establish our new facility at 108 Albert Road in Woodstock, Cape Town—expanding infrastructure.

We launch D-CYPHR, an advanced proteomics and metabolomics program supported by DIPLOMICS, DSTI, and TIA.

Empowered 1200+ OMICS
Projects

2024

We surpass 1200 OMICS research projects since launching in 2006—demonstrating our sustained impact and trusted expertise across academic and commercial sectors.